Press releases

In this section you can view all the latest news from across the Charity, from fundraising challenges to our information services and large-scale campaigns. Our team respond rapidly to new research, as well as to issues affecting men with prostate cancer and their families as they happen. Read our latest statements and responses on all aspects of the disease, including funding, treatment accessibility and emerging research.You can also search our archive of press releases.  

To register to receive our latest press releases please contact the press office, at pressoffice@prostatecanceruk.org.

Our busy Media and PR Team provide journalists with the most up-to-date and precise information on all aspects of prostate cancer, as quickly as possible. We deliver expert responses to the latest developments in prostate cancer research, as well as facts, figures and spokespeople to guide you through the issues surrounding the disease.

We also have access to around 150 people across the UK who have been affected by prostate cancer, and are willing to share their experiences with the media - our Media Talkers scheme.

In the Media Centre, you will find all our latest news releases and comments, as well as the resources you need to shape an article, including facts, statistics and profiles of our spokespeople.  If you do need any further information, you can also find the contact details for the Media and PR Team who will be able to help. 

Please note that the Media Centre is a tool for journalists. For all other enquiries, please contact the Prostate Cancer UK switchboard on 020 8222 7622.

Press releases

Sharleen Spiteri speaks out in support of The Prostate Cancer Charity

<p>Texas&nbsp;singer Sharleen Spiteri spoke exclusively to <a href="http://www.thesun.co.uk/scotsol/homepage/news/movember/3198174/Sharleen-Spiteri-tells-of-dads-cancer-battle-as-Movember-is-launched.html#ixzz13Xp2KEjT" target="_blank">The Scottish Sun</a> about her father's&nbsp;experience of&nbsp;prostate cancer&nbsp;in support of The Prostate Cancer Charity and&nbsp;Prostate Cancer Support Scotland's&nbsp;decision to join forces. The coming together of the&nbsp;charities will ensure that all men in Scotland&nbsp;will&nbsp;have access to good quality information to help them cope with the impact of the disease. Sharleen's support of the Charity&nbsp;was also featued in the <a href="http://www.dailyrecord.co.uk/videos-pics/2010/10/27/stars-back-new-scots-cancer-charity-86908-22661624/" target="_blank">Daily Record</a> and on <a href="http://news.stv.tv/scotland/205271-top-scots-give-backing-to-prostate-cancer-service/" target="_blank">STV</a>.</p>

Sharleen Spiteri and Lord David Steel

<p><span>Texas singer Sharleen Spiteri and <span>First Presiding Officer of the Scottish Parliament, Lord David Steel,&nbsp;have shown their backing&nbsp;of The Prostate Cancer Charity and Prostate Cancer Support Scotland's decision&nbsp;to join forces.</span></span></p>

New Urine test

<p><span>Dr Kate Holmes, Research Manager at The Prostate Cancer Charity, spoke to the Daily Mail, the Daily Telegraph,&nbsp;The Gu<span>a</span>rdian and BBC News Online&nbsp;about a new and&nbsp;reliable&nbsp;urine test which can detect whether men are at high risk of developing prostate cancer.</span></p>

Preliminary results of an abiraterone acetate trial

<p><span>John Neate, Chief Executive at The Prostate Cancer Charity,&nbsp;spoke to&nbsp;the&nbsp;Daily Telegraph, BBC Online and The Sun about the preliminary results of a trial of almost 800 men who took abiraterone acetate <span>and</span> lived almost four months longer than <span>men</span> given a placebo.</span></p>

University of Illinois Research

<div><span>Dr Kate Holmes, Research Manager at The Prostate Cancer Charity, spoke to the Daily Mail about new research&nbsp;carried out by the University of Illinois, which&nbsp;revealed that a chemical found in babies' bottles increase the risk of men developing prostate cancer later in life.</span></div> <div><span></span></div>

Cabazitaxel

<div><span><span><span>Dr Sarah Cant, Head of Policy and Campaigns at The Prostate Cancer Charity, spoke to the Daily Mail and the Daily Telegraph, about cabazitaxel,&nbsp; <span>a new drug</span> which could&nbsp; <span>give</span> men with advanced prostate cancer two extra months of life.<br /> </span></span></span></div>